caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1720152952

Win Kyi

General SurgeryDodge City, KSI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Win Kyi's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 21 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
DODGE CITY HEALTHCARE GROUP LLC2221,546
Laboratory Corporation Of America
Clinical Laboratory · Dallas, TX
102390
Carl Fieser
Diagnostic Radiology · Dodge City, KS
69285
Allison Schebler-Poulos
Family Practice · Corpus Christi, TX
58393
SHALBY, CYNTHIA40120
SHORT, BENNY33170
Charlie Matteson
Family Practice · Sioux Falls, SD
27150
NPI 12159038772573
James Moffitt
Family Practice · Ashland, KS
2076
Jason Nix
Certified Registered Nurse Anesthetist (CRNA) · Lufkin, TX
1849
Douglas Johnson
Family Practice · Ulysses, KS
1838
Jason Grennan
Diagnostic Radiology · Omaha, NE
1874
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
QUALITY · MIPS · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
39
Beneficiaries
—
Total drug cost
$590
Distinct drugs
3
Brand share
0.0%
Top prescribed drugs
Celecoxib16 claims
Hydralazine Hcl12 claims
Glimepiride11 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.